To the best of our knowledge, this is the first study to investigate EPO’s whole protective role, regarding its anti-inflammatory, antioxidant, and antiapoptotic effects simultaneously, in a bleomycin-induced IPF model through assessing specific biomarkers. This evidence concerns the gene EPO and idiopathic pulmonary fibrosis.